Loading.
Preparing your Shotlee experience
Authenticating
Loading health data
Syncing preferences
Health
Mounjaro Delivered: UAE App Introduces Weight-Loss Medication Delivery
S
Shotlee
Health & Wellness Team
4 min read
Preparing your Shotlee experience
A prominent home services company in the UAE has begun delivering weight-loss medications, indicating the sustained popularity of GLP-1 drugs. This move raises discussions about accessibility and safety when obtaining prescription drugs online.
A leading home services company is now offering home delivery of weight-loss drugs, highlighting the persistent demand for GLP-1 medications such as Wegovy and Mounjaro.
Justlife has expanded its services to include home delivery of these popular medications, adding to its existing offerings of home cleaning, pest control, air conditioning repairs, and personal grooming.
Operating in Dubai, Abu Dhabi, Sharjah, and Ajman, the company is collaborating with medical providers to facilitate the swift delivery of medications. These drugs function by mimicking glucagon-like peptide-1, a natural hormone that regulates blood sugar and aids in weight reduction.
While some UAE platforms offer supplements supporting GLP-1 treatments, prescription medications are generally not available for direct delivery through standard e-commerce channels.
Physicians emphasize the importance of exercising caution when acquiring prescription drugs online.
Dr. Ali El Houni, a consultant endocrinologist at Medcare Royal Speciality Hospital in Al Qusais, stated that increased access to GLP-1 receptor agonist medications has raised concerns about potential misuse. Cases of individuals obtaining or using these medications without proper assessment have emerged as availability expands, leading to worries about safety and misuse.
Significant safety issues arise from obtaining GLP-1 agonists online without medical supervision, including the risk of exposure to counterfeit or unapproved products, incorrect dosing potentially leading to overdose, and the possibility of severe, unmonitored adverse health effects.
Justlife has clarified that medications will only be delivered with a prescription and after a free online medical consultation.
A representative stated that Justlife connects users with licensed medical partners who handle all medical decisions, including consultations, assessments, prescriptions, and treatment plans. The licensed clinics manage all medication fulfillment, storage, and delivery processes within their regulated systems and in compliance with UAE regulations. Justlife does not handle or transport any medication.
In September, the European Medicines Agency issued a warning regarding the increasing prevalence of counterfeit GLP-1 drugs being sold online. The EMA and the Heads of Medicines Agencies reported a surge in illegal medicines marketed as GLP-1 receptor agonists, such as semaglutide, liraglutide, and tirzepatide, for weight loss and diabetes, sold through fraudulent websites and promoted on social media. Ensuring access to these medications is limited to verified, medically supervised channels is crucial to preventing health risks, according to Dr. El Houni. Health tracking apps like Shotlee can help monitor medication adherence and potential side effects.
The popularity of weight loss drugs has surged, and doctors suggest that home delivery could alleviate supply and demand challenges faced by some individuals.
Health insurance typically does not cover the cost of these medications, which can reach up to Dh2,000 per month's supply. Patients must also meet specific criteria, such as having a high BMI and demonstrating lifestyle changes, to qualify.
Strong demand is driving pressure on the US Food and Drug Administration to approve the use of these drugs for treating other conditions, including kidney and liver disease, and heart failure.
According to UnitedHealthcare, US spending on GLP-1 medications increased by 500% between 2018 and 2023, reaching $71.7 billion, with two in five Americans now classified as obese.
The Ministry of Health and Prevention reported that approximately 28% of adults in the UAE are obese, as of 2023.
Eli Lilly, the manufacturer of Mounjaro, recently became the first pharmaceutical company to achieve a market value of $1 trillion, largely fueled by the booming demand for weight loss drugs.
The demand is also reshaping diagnostic practices in India, with a sharp increase in requests for metabolic testing driven by the use of drugs for obesity management and type-2 diabetes.
The expiration of patents on existing drugs in 2026 is expected to pave the way for the availability of cheaper, generic versions, potentially improving access.
Dr. Noor Naji, a consultant and head of internal medicine at Burjeel Medical City, believes that delivering drugs through a third party could ease logistical pressures on pharmacies.
Dr. Naji stated that GLP-1 drugs are generally excellent medications, noting the positive results she has observed in patients who genuinely need them, including weight loss, improved blood sugar levels, enhanced fatty liver markers, reduced joint pain, increased energy levels, and positive psychological effects.
She recommends delivery for many patients who prefer to avoid long wait times at the pharmacy. Storage requirements, such as maintaining a cool temperature, can also make delivery a more convenient option.
Dr. Naji emphasized the importance of medical consultation for individuals taking these drugs, to ensure proper injection techniques and awareness of potential side effects. Close monitoring is essential, particularly for first-time users, and doctors should always counsel patients on their specific needs.
⚠️ Disclaimer: This article is for informational purposes only. Consult your healthcare provider before starting any medication or supplement.
Original content from The National
View Original Article
An affordable and readily accessible medication is gaining attention as a potential solution for curbing alcohol cravings, drawing comparisons to the way GLP-1 drugs manage food cravings. Naltrexone, by impacting dopamine-reward pathways, reduces the satisfying feeling associated with alcohol consumption, thus diminishing the desire for it. Research and anecdotal evidence suggest it could be a game-changer for many.
Mounjaro, a drug by Eli Lilly, is set to be included in China's state-run health insurance program for individuals with type 2 diabetes starting January 1. This inclusion aims to improve access to the medication, although increased sales may be balanced by reduced prices. The drug was introduced in China earlier this year.
The World Health Organization (WHO) has provided new guidance on using GLP-1 drugs like Ozempic and Wegovy for obesity. The recommendations include considerations for adults and highlight the importance of lifestyle changes alongside medication.
Monitor GLP-1 medications, peptide therapy, weight loss, and wellness metrics with our comprehensive health tracking app. Join thousands of users taking control of their health!
Start Tracking Free Forever! ✨